JNE Partners LLP - Q2 2021 holdings

$136 Million is the total value of JNE Partners LLP's 11 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 88.9% .

 Value Shares↓ Weighting
CMCSA  COMCAST CORP NEWcl a$32,040,000
+5.4%
561,9020.0%23.52%
+22.7%
UHAL SellAMERCO$29,957,000
-23.6%
50,826
-20.6%
21.99%
-11.1%
NG  NOVAGOLD RES INC$15,660,000
-8.6%
1,955,0470.0%11.49%
+6.5%
MSDAU  MSD ACQUISITION CORPunit 03/25/2026$15,150,000
-0.5%
1,500,0000.0%11.12%
+15.9%
ORIAU NewORION BIOTECH OPPORTUNTES COunit 04/15/2025$15,075,0001,500,000
+100.0%
11.06%
EOCWU NewELLIOTT OPPORTUNITY II CORPunit 99/99/9999$11,011,0001,100,000
+100.0%
8.08%
WALD NewWALDENCAST ACQUISITION CORP$9,950,0001,000,000
+100.0%
7.30%
RKTAU BuyROCKET INTERNET GRWT OPRT COunit 99/99/9999$4,307,0000.0%430,234
+969.3%
3.16%
+16.4%
KAHCU  KKR ACQUISITION HOLDING I COunit 99/99/9999$2,308,000
+0.3%
229,8660.0%1.69%
+16.8%
LMACA NewLIBERTY MEDIA ACQUISITION CO$429,00042,126
+100.0%
0.32%
WALDW NewWALDENCAST ACQUISITION CORP*w exp 03/11/202$367,000333,333
+100.0%
0.27%
WALDU ExitWALDENCAST ACQUISITION CORPunit 03/11/2026$0-1,000,000
-100.0%
-6.30%
SCHW ExitSCHWAB CHARLES CORP$0-153,500
-100.0%
-6.31%
TSLA ExitTESLA INCput$0-45,000
-100.0%
-18.94%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings